Back

Does dual-antiplatelet therapy decrease the risk of stroke following coronary artery bypass grafting?

28 August 2017 (15:35 - 16:25)
Organised by:
Congress Presentation Part of: Advances in cardiovascular surgery Stroke ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Patrick Daniele

University of British Columbia, Vancouver (Canada)

6 More presentations in this session

Presentation thumbnail
Influence of peri-operative stroke on 5-year mortality following open heart surgery
Mr P. Daniele (Vancouver, CA)
Abstract Slides
Presentation thumbnail
A more restrictive transfusion policy modifies the impact of preoperative anemia on strokes and other outcomes after cardiac surgery in adults.
Professor T. Caus (Amiens, FR)
Abstract Slides
Presentation thumbnail
Emergency endovascular repair for acute traumatic thoracic aortic transection
Doctor X. Pu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Clinical outcomes of patients with abdominal aortic aneurysm after endovascular repair according to combined presence of coronary or peripheral artery disease
Doctor O. Lee (Yongin, KR)
Abstract Slides
Presentation thumbnail
Are morphologic findings of aortic intramural haematoma predictors of mortality in acute phase?
Doctor S. Moral (Girona, ES)
Abstract Slides

Access the full session

Session thumbnail
Advances in cardiovascular surgery

The Event

Event poster

ESC Congress 2017

28 August 2017 15:35 CET
You may be interested in
thumbnail
Congress Presentation
Safety of dual antiplatelet pre-treatment in ACS patients undergoing unplanned aortocoronary bypass surgery
15 March 2025
thumbnail
Webinar
Balancing stroke and bleeding risks in patients with AF and concomitant coronary artery disease, malignancy, chronic kidney disease, or frailty
10 November 2025
thumbnail
Congress Presentation
Cerebral injuries following coronary bypass surgery
30 August 2025
thumbnail
Congress Presentation
Risk of myocardial infarction with coronary artery bypass grafting versus percutaneous coronary intervention: a systematic review and meta-analysis of fifteen randomised trials
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources